Yu, Justin
Gadwa, Jacob
Ross, Richard B.
Knitz, Michael
Darragh, Laurel B.
Abdelazeem, Khalid N. M.
Beynor, Jessica
Neupert, Brooke
Nguyen, Alexander
Nguyen, Diemmy
Olimpo, Nicholas
Corbo, Sophia
Van Court, Benjamin
D’Alessandro, Angelo
Saviola, Anthony
Karam, Sana D.
Funding for this research was provided by:
National Institutes of Health (5T32DC012280-09)
NIDCR/NCI (R01 DE028528-01)
Article History
Received: 8 January 2024
Accepted: 27 February 2024
First Online: 30 March 2024
Declarations
:
: S.D.K. receives clinical funding from Genentech, AstraZeneca, and Ionis that does not relate to this work. She also receives preclinical research funding from Roche and Amgen unrelated to this work. A.D. is a founder of Omix Technologies Inc and Altis Biosciences, and advisory board member for Hemanext Inc and Macopharma Inc.